Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark I Greene

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Methods (San Diego, Calif.)|October 22, 2008
Methods. Guest editor's introductionMark I Greene
Current Opinion in Immunology|October 20, 2010
Regulation of the immune responseMark I Greene, Herman Waldmann
Experimental and Molecular Pathology|June 25, 2005
EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathwayQiang Wang, Mark I Greene
Nature Immunology|December 21, 2010
Cooperative regulatory events and Foxp3 expressionMasahide Tone, Mark I Greene
Immunology|December 25, 2007
Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppressionBin Li, Mark I Greene
Molecular Systems Biology|October 4, 2006
Towards comprehensive characterization of HER2 overexpressionAlan Berezov, Mark I Greene
Cell Cycle (Georgetown, Tex.)|June 27, 2007
FOXP3 actively represses transcription by recruiting the HAT/HDAC complexBin Li, Mark I Greene
Cancers|May 11, 2024
Survivin as a Therapeutic Target for the Treatment of Human CancerQiang Wang, Mark I Greene
The Journal of Clinical Investigation|June 24, 2008
Mechanisms of resistance to ErbB-targeted cancer therapeuticsQiang Wang, Mark I Greene
Pharmaceuticals (Basel, Switzerland)|November 30, 2013
Structure based antibody-like peptidomimeticsRamachandran Murali, Mark I Greene
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Methods (San Diego, Calif.)|October 22, 2008
Methods. Guest editor's introductionMark I Greene
Current Opinion in Immunology|October 20, 2010
Regulation of the immune responseMark I Greene, Herman Waldmann
Experimental and Molecular Pathology|June 25, 2005
EGFR enhances Survivin expression through the phosphoinositide 3 (PI-3) kinase signaling pathwayQiang Wang, Mark I Greene
Nature Immunology|December 21, 2010
Cooperative regulatory events and Foxp3 expressionMasahide Tone, Mark I Greene
Immunology|December 25, 2007
Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppressionBin Li, Mark I Greene
Molecular Systems Biology|October 4, 2006
Towards comprehensive characterization of HER2 overexpressionAlan Berezov, Mark I Greene
Cell Cycle (Georgetown, Tex.)|June 27, 2007
FOXP3 actively represses transcription by recruiting the HAT/HDAC complexBin Li, Mark I Greene
Cancers|May 11, 2024
Survivin as a Therapeutic Target for the Treatment of Human CancerQiang Wang, Mark I Greene
The Journal of Clinical Investigation|June 24, 2008
Mechanisms of resistance to ErbB-targeted cancer therapeuticsQiang Wang, Mark I Greene
Pharmaceuticals (Basel, Switzerland)|November 30, 2013
Structure based antibody-like peptidomimeticsRamachandran Murali, Mark I Greene
Pageof 12